Loading…
Greenpark Compounding Pharmacy received an FDA Warning Letter on October 26, 2018, regarding drug manufacturing or compounding practices. Based on the limited metadata available, the specific violations cannot be detailed without access to the full letter text. The warning falls under FDA's drug product regulatory authority, though the issuing office is not specified in the available information.